Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Despite Years in the Biz, Meta Materials Is an Aspirational Firm

By Josh Enomoto, InvestorPlace Contributor

While MMAT stock never falls short on potential, the underlying company has been struggling to really make it big.

7 Stocks to Sell You Can Feel Good About Dumping

By Josh Enomoto, InvestorPlace Contributor

While broaching the subject of stocks to sell is always controversial, you’ll find less friction with these questionable investments.

7 Stocks to Buy as America Lifts Its Travel Ban

By Josh Enomoto, InvestorPlace Contributor

With the Biden administration making the move to open U.S. land borders with Canada and Mexico, these stocks to buy can get a boost.

Don’t Kick Pupcoin Floki Inu to the Doghouse Just Yet

By Josh Enomoto, InvestorPlace Contributor

Although Floki Inu is in rough shape following the cryptocurrency fallout, as a strategic play, FLOKI-USD offers a compelling narrative.

7 Cryptocurrencies to Consider in Light of the Bitcoin Beatdown

By Josh Enomoto, InvestorPlace Contributor

With Bitcoin suffering a sizable loss of market value, investors may be better served by buying less-talked-about cryptos.

Progenity Has Too Many Problems, Not Enough Money?

By Josh Enomoto, InvestorPlace Contributor

One of the many recent IPOs since the Covid-19 pandemic, PROG stock has encountered numerous setbacks to be a comfortable ride. With their partnership with Avero Diagnotics, management is currently refocusing efforts and resources, seeking "strategic alternatives" to help the company soar.

7 Hotly Anticipated SPACs That Could Sizzle Now Through 2022

By Josh Enomoto, InvestorPlace Contributor

If you understand the risks of reverse mergers and are willing to take some blind bets, here are the SPACs that deliver the intrigue.

Lucid is Firing on All Cylinders Despite Earnings Whiff

By Josh Enomoto, InvestorPlace Contributor

The Lucid Air received one of the auto industry's highest honors, making the narrative underlying LCID stock even more compelling.

The 10 Best Cryptos, NFTs and Stocks to Buy as Christmas Gifts This Year

By Josh Enomoto, InvestorPlace Contributor

With the supply chain crisis wreaking havoc on the holidays, you should instead consider gifting these cryptos, NFTs and stocks to buy.

Ocugen Proves Groupthink Is a Double-Edged Sword

By Josh Enomoto, InvestorPlace Contributor

While OCGN stock is an intriguing idea on the science, when the masses have a different framework, it becomes a risky proposition.

Load More